ACE inhibitors have been shown to be effective in reducing the morbidity and mortality of
patients with left ventricular systolic dysfunction, but their application to clinical practice in …

Currently there is concern that ACE inhibitors are not being utilised to their maximum
potential for the prevention or treatment of heart failure. Underutilisation of ACE inhibitors …

Angiotensin-converting enzyme (ACE) inhibitors are now accepted as part of the routine
management of patients with heart failure. Their use has been mandated in all the new …

Although the beneficial effects of angiotensin-con verting enzyme (ACE) inhibitors on symp
toms. morbidity and mortality have been proven beyond any doubt, some controversies …

Angiotensin-converting enzyme inhibitors (ACE inhibitors) have been shown to be effective
in improving symptoms and survival in patients with systolic left ventricular dysfunction …

Large-scale trials have demonstrated a consistent mortality reduction from angiotensin
converting enzyme (ACE) inhibitor therapy for chronic heart failure. Nonetheless, the …

Angiotensin-converting enzyme inhibitors (ACE-I) have been proven to be effective in
reducing morbidity and mortality in patients with heart failure or post-myocardial infarction …

Although the beneficial effects of angiotensin‐converting enzyme (ACE) inhibitors in patients
with ventricular systolic dysfunction are well documented, historically, a large proportion of …

Our understanding of the clinical course of heart failure and the mechanism by which ACE
inhibitors reduce mortality and morbidity is being enhanced by recent results from large …

ACE inhibitors have significantly decreased cardiovascular mortality, myocardial infarction
(MI), and hospitalizations for heart failure (HF) in patients with asymptomatic or symptomatic …